The reported method focused on two types on kinase inhibitors (type I and I 1 /2), however other libraries could be generated by fragmenting other kinase inhibitor types. Similarly, the same protocol could be applied to a more specific set of ligands, e.g to design a library of fragments specific of a kinase group, or a different dataset of ligand-kinase 3D structures.